Endocrinological abnormalities and Takotsubo cardiomyopathy

Published: April 12, 2021
Abstract Views: 958
PDF: 514
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Dear Editor,

We read with much excitement in the article “Takotsubo syndrome and pheochromocytoma: an insidious combination” published by Maffé et al. in your esteemed journal...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Maffè S, Dellavesa P, Paffoni P, et al. Takotsubo syndrome and pheochromocytoma: An insidious combination. Monaldi Arch Chest Dis 2021. Online ahead of print. https://doi.org/10.4081/monaldi.2021.1711 DOI: https://doi.org/10.4081/monaldi.2021.1711
De Giorgi A, Fabbian F, Tiseo R, et al. Takotsubo cardiomyopathy and endocrine disorders: a mini-review of case reports. Am J Emerg Med 2014;32:1413-7. DOI: https://doi.org/10.1016/j.ajem.2014.07.030
Gupta S, Goyal P, Idrees S, et al. Association of endocrine conditions with takotsubo cardiomyopathy: A comprehensive review. J Am Heart Assoc 2018;7:e009003. DOI: https://doi.org/10.1161/JAHA.118.009003
Pelliccia F, Pasceri V, Patti G, et al. Long-term prognosis and outcome predictors in takotsubo syndrome: A systematic review and meta-regression study. JACC Heart Fail 2019;7:143-54. DOI: https://doi.org/10.1016/j.jchf.2018.10.009

How to Cite

George, Anu Anna, Kevin John John, Vijairam Selvaraj, and Ajay Kumar Mishra. 2021. “Endocrinological Abnormalities and Takotsubo Cardiomyopathy”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1859.

Similar Articles

You may also start an advanced similarity search for this article.